Table of Contents
<< Previous Issue | Mar 2008 (Vol: 2008, Issue: 93) | Next Issue >> |
- Section: Business Commentaries
-
Patent Reform Could Threaten Innovation
- Section: Cartoons
-
Patent
- Section: Company Profile
-
Novo Nordisk AS
- Section: Deal Trackers
-
Yondelis (Trabectedin)
- Section: Features
-
Amgen Forced to Surrender Japan
-
Expanding Large Molecule Capabilities: Teva#8217;s Latest Acquisition
-
The War Dividend
-
Therapy Focus #8211; Melanoma Vaccines
- Section: General
-
Clinical Development Attrition Rates
- Section: Licensing
-
Forest Licenses Novexel’s Novel Broad-Spectrum Beta-Lactamase Inhibitor
-
Nycomed Finds Commercialisation Partner for Ciclesonide
- Section: Mergers & Acquisitions
-
GE Healthcare Acquires Whatman
- Section: Research & Development
-
Acceleron Signs Deals for Bone-Forming Compounds